Jade Capital Advisors’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-180,000
Closed -$2.47M 104
2023
Q4
$2.47M Sell
180,000
-150,000
-45% -$1.58M 1.47% 24
2023
Q3
$2.68M Buy
330,000
+20,000
+6% +$163K 2.41% 9
2023
Q2
$2.35M Buy
310,000
+40,000
+15% +$305K 1.83% 22
2023
Q1
$2.16M Buy
270,000
+50,000
+23% +$514K 2.99% 11
2022
Q4
$2.5M Buy
220,000
+130,000
+144% +$1.42M 7.28% 1
2022
Q3
$786K Buy
90,000
+70,000
+350% +$727K 4.06% 10
2022
Q2
$199K Sell
20,000
-25,000
-56% -$252K ﹤0.01% 23
2022
Q1
$453K Hold
45,000
0.24% 84
2021
Q4
$626K Hold
45,000
0.47% 53
2021
Q3
$563K Buy
+45,000
New +$611K 0.33% 62

Other funds holding PTVE

Jade Capital Advisors's PTVE Position: Q1 2024 in Review

Jade Capital Advisors sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q1 2024, closing a stake of 180,000 shares — an estimated $2.47M sold.

Jade Capital Advisors first reported a position in PTVE in Q3 2021 and held it in 10 quarters. The position peaked at $2.68M in Q3 2023. 148 funds tracked by Wall St. Rank hold PTVE as of Q1 2024.

  • Jade Capital Advisors reported no remaining Pactiv Evergreen Inc. Common stock position as of Q1 2024 after selling out during the quarter.
  • Jade Capital Advisors sold 180,000 Pactiv Evergreen Inc. Common stock shares in Q1 2024, an estimated $2.47M.
  • Jade Capital Advisors first reported a position in Pactiv Evergreen Inc. Common stock in Q3 2021 and held it in 10 quarters.
  • Jade Capital Advisors's Pactiv Evergreen Inc. Common stock position peaked at $2.68M in Q3 2023.
  • 148 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q1 2024.

Based on Jade Capital Advisors's 13F filing for Q1 2024, filed 10 May 2024.